Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Executive Chairman

Chief Product Officer

Principal Accounting Officer

Chief Medical Officer

Chief Executive Officer

See Remarks

Chief Financial Officer

Chief Commercial Officer

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the cau...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-09	Premium	acquired	Premium	Premium	Premium	Executive Chairman
2024-01-09	Premium	acquired	Premium	Premium	Premium	Executive Chairman
2023-12-18	Premium	acquired	Premium	Premium	Premium	Chief Product Officer
2023-12-18	Premium	acquired	Premium	Premium	Premium	Principal Accounting Officer
2023-12-18	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-12-18	Premium	acquired	Premium	Premium	Premium	-
2023-12-18	Premium	acquired	Premium	Premium	Premium	-
2023-12-18	Premium	acquired	Premium	Premium	Premium	Executive Chairman
2023-12-18	Premium	acquired	Premium	Premium	Premium	-
2023-12-18	Premium	acquired	Premium	Premium	Premium	-
2023-12-18	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-12-18	Premium	acquired	Premium	Premium	Premium	-
2023-07-27	Premium	bought	Premium	Premium	Premium	-
2023-07-27	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2023-07-27	Premium	bought	Premium	Premium	Premium	-
2023-07-27	Premium	bought	Premium	Premium	Premium	-
2023-07-27	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-07-27	Premium	bought	Premium	Premium	Premium	Executive Chairman
2023-05-16	Premium	bought	Premium	Premium	Premium	-
2023-04-10	Premium	bought	Premium	Premium	Premium	See Remarks
2023-04-10	Premium	bought	Premium	Premium	Premium	See Remarks
2023-04-10	Premium	bought	Premium	Premium	Premium	See Remarks
2023-04-10	Premium	bought	Premium	Premium	Premium	-
2023-04-10	Premium	bought	Premium	Premium	Premium	-
2023-04-05	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer

BTTX - Better Therapeutics, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for BTTX